CIK 0001563880
- Non-accelerated filer
- Smaller reporting company
Trevi Therapeutics, Inc.
Sign in to watch- Ticker
- TRVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450834299
- Phone
- +1 203-304-2499
- Business address
- 195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
- 4 Open-market buy 10% owner bought 2,500,000 shares at $10.00 ($25,000,000)
- 4 Open-market buy 10% owner bought 2,500,000 shares at $10.00 ($25,000,000)
- 4 Conversion 10% owner acquired 62,540 shares (conversion)
- 4 Open-market buy Director bought 11,250 shares at $10.00 ($112,500)
- 4 Open-market buy 10% owner bought 481,000 shares at $10.00 ($4,810,000)
- 4 Open-market buy 10% owner bought 100,000 shares at $10.00 ($1,000,000)
- 4 Conversion 10% owner acquired 99,046 shares (conversion)
- 4 Open-market buy Director bought 2,500 shares at $10.00 ($25,000)
- 4 Open-market buy GOOD JENNIFER L bought 11,250 shares at $10.00 ($112,500)
- 4 Open-market buy 10% owner bought 112,000 shares at $10.00 ($1,120,000)
- 4 Open-market buy Director bought 375,000 shares at $10.00 ($3,750,000)
- 4 Open-market buy 10% owner bought 100,000 shares at $10.00 ($1,000,000)
- 4 Open-market buy Director bought 5,000 shares at $10.00 ($50,000)
- 4 Open-market buy 10% owner bought 375,000 shares at $10.00 ($3,750,000)
- 4 Conversion 10% owner acquired 62,540 shares (conversion)
- 4 Conversion Chief Medical Officer acquired 17,118 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 13 · 257 filings